Loading…

Dialysis Modalities and HDL Composition and Function

Lipid abnormalities may have an effect on clinical outcomes of patients on dialysis. Recent studies have indicated that HDL dysfunction is a hallmark of ESRD. In this study, we compared HDL composition and metrics of HDL functionality in patients undergoing hemodialysis (HD) or peritoneal dialysis (...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Society of Nephrology 2015-09, Vol.26 (9), p.2267-2276
Main Authors: Holzer, Michael, Schilcher, Gernot, Curcic, Sanja, Trieb, Markus, Ljubojevic, Senka, Stojakovic, Tatjana, Scharnagl, Hubert, Kopecky, Chantal M, Rosenkranz, Alexander R, Heinemann, Akos, Marsche, Gunther
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c390t-553399dd4b46d015bc7632f5d19d9da2240731e77191094d26b58ef9b96408d33
cites cdi_FETCH-LOGICAL-c390t-553399dd4b46d015bc7632f5d19d9da2240731e77191094d26b58ef9b96408d33
container_end_page 2276
container_issue 9
container_start_page 2267
container_title Journal of the American Society of Nephrology
container_volume 26
creator Holzer, Michael
Schilcher, Gernot
Curcic, Sanja
Trieb, Markus
Ljubojevic, Senka
Stojakovic, Tatjana
Scharnagl, Hubert
Kopecky, Chantal M
Rosenkranz, Alexander R
Heinemann, Akos
Marsche, Gunther
description Lipid abnormalities may have an effect on clinical outcomes of patients on dialysis. Recent studies have indicated that HDL dysfunction is a hallmark of ESRD. In this study, we compared HDL composition and metrics of HDL functionality in patients undergoing hemodialysis (HD) or peritoneal dialysis (PD) with those in healthy controls. We detected a marked suppression of several metrics of HDL functionality in patients on HD or PD. Compositional analysis revealed that HDL from both dialysis groups shifted toward a more proinflammatory phenotype with profound alterations in the lipid moiety and protein composition. With regard to function, cholesterol efflux and anti-inflammatory and antiapoptotic functions seemed to be more severely suppressed in patients on HD, whereas HDL-associated paraoxonase activity was lowest in patients on PD. Quantification of enzyme activities involved in HDL metabolism suggested that HDL particle maturation and remodeling are altered in patients on HD or PD. In summary, our study provides mechanistic insights into the formation of dysfunctional HDL in patients with ESRD who are on HD or PD.
doi_str_mv 10.1681/ASN.2014030309
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4552105</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1708903788</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-553399dd4b46d015bc7632f5d19d9da2240731e77191094d26b58ef9b96408d33</originalsourceid><addsrcrecordid>eNpVUD1PwzAUtBCIlsLKiDKypPjb8YJUtZQiFRiA2XJiB4ySuMQJUv89Li0F9Ib3de_e6QA4R3CMeIauJk8PYwwRhSSGPABDxAhJCWXwMNaQ8pRzQQbgJIR3CBHDQhyDAWYiIrAYAjpzuloHF5J7b3TlOmdDohuTLGbLZOrrlQ9x5pvv2bxvik1zCo5KXQV7tssj8DK_eZ4u0uXj7d10skwLImGXsihFSmNoTrmJv_NCcIJLZpA00miMKRQEWSGQRFBSg3nOMlvKXHIKM0PICFxveVd9XltT2KZrdaVWrat1u1ZeO_V_07g39eo_FWUMI8giweWOoPUfvQ2dql0obFXpxvo-KCRgJiERWRah4y20aH0IrS33bxBUG6tVtFr9Wh0PLv6K28N_vCVfsXx4AQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1708903788</pqid></control><display><type>article</type><title>Dialysis Modalities and HDL Composition and Function</title><source>PubMed Central Free</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Holzer, Michael ; Schilcher, Gernot ; Curcic, Sanja ; Trieb, Markus ; Ljubojevic, Senka ; Stojakovic, Tatjana ; Scharnagl, Hubert ; Kopecky, Chantal M ; Rosenkranz, Alexander R ; Heinemann, Akos ; Marsche, Gunther</creator><creatorcontrib>Holzer, Michael ; Schilcher, Gernot ; Curcic, Sanja ; Trieb, Markus ; Ljubojevic, Senka ; Stojakovic, Tatjana ; Scharnagl, Hubert ; Kopecky, Chantal M ; Rosenkranz, Alexander R ; Heinemann, Akos ; Marsche, Gunther</creatorcontrib><description>Lipid abnormalities may have an effect on clinical outcomes of patients on dialysis. Recent studies have indicated that HDL dysfunction is a hallmark of ESRD. In this study, we compared HDL composition and metrics of HDL functionality in patients undergoing hemodialysis (HD) or peritoneal dialysis (PD) with those in healthy controls. We detected a marked suppression of several metrics of HDL functionality in patients on HD or PD. Compositional analysis revealed that HDL from both dialysis groups shifted toward a more proinflammatory phenotype with profound alterations in the lipid moiety and protein composition. With regard to function, cholesterol efflux and anti-inflammatory and antiapoptotic functions seemed to be more severely suppressed in patients on HD, whereas HDL-associated paraoxonase activity was lowest in patients on PD. Quantification of enzyme activities involved in HDL metabolism suggested that HDL particle maturation and remodeling are altered in patients on HD or PD. In summary, our study provides mechanistic insights into the formation of dysfunctional HDL in patients with ESRD who are on HD or PD.</description><identifier>ISSN: 1046-6673</identifier><identifier>EISSN: 1533-3450</identifier><identifier>DOI: 10.1681/ASN.2014030309</identifier><identifier>PMID: 25745027</identifier><language>eng</language><publisher>United States: American Society of Nephrology</publisher><subject>1-Alkyl-2-acetylglycerophosphocholine Esterase - metabolism ; Aged ; Aryldialkylphosphatase - metabolism ; Case-Control Studies ; Cells, Cultured ; Cholesterol - metabolism ; Cholesterol Ester Transfer Proteins - blood ; Clinical Research ; Female ; Humans ; Kidney Failure, Chronic - blood ; Kidney Failure, Chronic - enzymology ; Kidney Failure, Chronic - therapy ; Lipopolysaccharides - pharmacology ; Lipoprotein Lipase - blood ; Lipoproteins, HDL - blood ; Lipoproteins, HDL - chemistry ; Lipoproteins, HDL - pharmacology ; Macrophages - metabolism ; Male ; Middle Aged ; Monocytes - drug effects ; Monocytes - metabolism ; NF-kappa B - metabolism ; Peritoneal Dialysis ; Phosphatidylcholine-Sterol O-Acyltransferase - blood ; Phospholipid Transfer Proteins - blood ; Renal Dialysis - methods ; Triglycerides - blood</subject><ispartof>Journal of the American Society of Nephrology, 2015-09, Vol.26 (9), p.2267-2276</ispartof><rights>Copyright © 2015 by the American Society of Nephrology.</rights><rights>Copyright © 2015 by the American Society of Nephrology 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-553399dd4b46d015bc7632f5d19d9da2240731e77191094d26b58ef9b96408d33</citedby><cites>FETCH-LOGICAL-c390t-553399dd4b46d015bc7632f5d19d9da2240731e77191094d26b58ef9b96408d33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552105/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552105/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25745027$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Holzer, Michael</creatorcontrib><creatorcontrib>Schilcher, Gernot</creatorcontrib><creatorcontrib>Curcic, Sanja</creatorcontrib><creatorcontrib>Trieb, Markus</creatorcontrib><creatorcontrib>Ljubojevic, Senka</creatorcontrib><creatorcontrib>Stojakovic, Tatjana</creatorcontrib><creatorcontrib>Scharnagl, Hubert</creatorcontrib><creatorcontrib>Kopecky, Chantal M</creatorcontrib><creatorcontrib>Rosenkranz, Alexander R</creatorcontrib><creatorcontrib>Heinemann, Akos</creatorcontrib><creatorcontrib>Marsche, Gunther</creatorcontrib><title>Dialysis Modalities and HDL Composition and Function</title><title>Journal of the American Society of Nephrology</title><addtitle>J Am Soc Nephrol</addtitle><description>Lipid abnormalities may have an effect on clinical outcomes of patients on dialysis. Recent studies have indicated that HDL dysfunction is a hallmark of ESRD. In this study, we compared HDL composition and metrics of HDL functionality in patients undergoing hemodialysis (HD) or peritoneal dialysis (PD) with those in healthy controls. We detected a marked suppression of several metrics of HDL functionality in patients on HD or PD. Compositional analysis revealed that HDL from both dialysis groups shifted toward a more proinflammatory phenotype with profound alterations in the lipid moiety and protein composition. With regard to function, cholesterol efflux and anti-inflammatory and antiapoptotic functions seemed to be more severely suppressed in patients on HD, whereas HDL-associated paraoxonase activity was lowest in patients on PD. Quantification of enzyme activities involved in HDL metabolism suggested that HDL particle maturation and remodeling are altered in patients on HD or PD. In summary, our study provides mechanistic insights into the formation of dysfunctional HDL in patients with ESRD who are on HD or PD.</description><subject>1-Alkyl-2-acetylglycerophosphocholine Esterase - metabolism</subject><subject>Aged</subject><subject>Aryldialkylphosphatase - metabolism</subject><subject>Case-Control Studies</subject><subject>Cells, Cultured</subject><subject>Cholesterol - metabolism</subject><subject>Cholesterol Ester Transfer Proteins - blood</subject><subject>Clinical Research</subject><subject>Female</subject><subject>Humans</subject><subject>Kidney Failure, Chronic - blood</subject><subject>Kidney Failure, Chronic - enzymology</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Lipoprotein Lipase - blood</subject><subject>Lipoproteins, HDL - blood</subject><subject>Lipoproteins, HDL - chemistry</subject><subject>Lipoproteins, HDL - pharmacology</subject><subject>Macrophages - metabolism</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Monocytes - drug effects</subject><subject>Monocytes - metabolism</subject><subject>NF-kappa B - metabolism</subject><subject>Peritoneal Dialysis</subject><subject>Phosphatidylcholine-Sterol O-Acyltransferase - blood</subject><subject>Phospholipid Transfer Proteins - blood</subject><subject>Renal Dialysis - methods</subject><subject>Triglycerides - blood</subject><issn>1046-6673</issn><issn>1533-3450</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpVUD1PwzAUtBCIlsLKiDKypPjb8YJUtZQiFRiA2XJiB4ySuMQJUv89Li0F9Ib3de_e6QA4R3CMeIauJk8PYwwRhSSGPABDxAhJCWXwMNaQ8pRzQQbgJIR3CBHDQhyDAWYiIrAYAjpzuloHF5J7b3TlOmdDohuTLGbLZOrrlQ9x5pvv2bxvik1zCo5KXQV7tssj8DK_eZ4u0uXj7d10skwLImGXsihFSmNoTrmJv_NCcIJLZpA00miMKRQEWSGQRFBSg3nOMlvKXHIKM0PICFxveVd9XltT2KZrdaVWrat1u1ZeO_V_07g39eo_FWUMI8giweWOoPUfvQ2dql0obFXpxvo-KCRgJiERWRah4y20aH0IrS33bxBUG6tVtFr9Wh0PLv6K28N_vCVfsXx4AQ</recordid><startdate>20150901</startdate><enddate>20150901</enddate><creator>Holzer, Michael</creator><creator>Schilcher, Gernot</creator><creator>Curcic, Sanja</creator><creator>Trieb, Markus</creator><creator>Ljubojevic, Senka</creator><creator>Stojakovic, Tatjana</creator><creator>Scharnagl, Hubert</creator><creator>Kopecky, Chantal M</creator><creator>Rosenkranz, Alexander R</creator><creator>Heinemann, Akos</creator><creator>Marsche, Gunther</creator><general>American Society of Nephrology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150901</creationdate><title>Dialysis Modalities and HDL Composition and Function</title><author>Holzer, Michael ; Schilcher, Gernot ; Curcic, Sanja ; Trieb, Markus ; Ljubojevic, Senka ; Stojakovic, Tatjana ; Scharnagl, Hubert ; Kopecky, Chantal M ; Rosenkranz, Alexander R ; Heinemann, Akos ; Marsche, Gunther</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-553399dd4b46d015bc7632f5d19d9da2240731e77191094d26b58ef9b96408d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>1-Alkyl-2-acetylglycerophosphocholine Esterase - metabolism</topic><topic>Aged</topic><topic>Aryldialkylphosphatase - metabolism</topic><topic>Case-Control Studies</topic><topic>Cells, Cultured</topic><topic>Cholesterol - metabolism</topic><topic>Cholesterol Ester Transfer Proteins - blood</topic><topic>Clinical Research</topic><topic>Female</topic><topic>Humans</topic><topic>Kidney Failure, Chronic - blood</topic><topic>Kidney Failure, Chronic - enzymology</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Lipoprotein Lipase - blood</topic><topic>Lipoproteins, HDL - blood</topic><topic>Lipoproteins, HDL - chemistry</topic><topic>Lipoproteins, HDL - pharmacology</topic><topic>Macrophages - metabolism</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Monocytes - drug effects</topic><topic>Monocytes - metabolism</topic><topic>NF-kappa B - metabolism</topic><topic>Peritoneal Dialysis</topic><topic>Phosphatidylcholine-Sterol O-Acyltransferase - blood</topic><topic>Phospholipid Transfer Proteins - blood</topic><topic>Renal Dialysis - methods</topic><topic>Triglycerides - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Holzer, Michael</creatorcontrib><creatorcontrib>Schilcher, Gernot</creatorcontrib><creatorcontrib>Curcic, Sanja</creatorcontrib><creatorcontrib>Trieb, Markus</creatorcontrib><creatorcontrib>Ljubojevic, Senka</creatorcontrib><creatorcontrib>Stojakovic, Tatjana</creatorcontrib><creatorcontrib>Scharnagl, Hubert</creatorcontrib><creatorcontrib>Kopecky, Chantal M</creatorcontrib><creatorcontrib>Rosenkranz, Alexander R</creatorcontrib><creatorcontrib>Heinemann, Akos</creatorcontrib><creatorcontrib>Marsche, Gunther</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the American Society of Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Holzer, Michael</au><au>Schilcher, Gernot</au><au>Curcic, Sanja</au><au>Trieb, Markus</au><au>Ljubojevic, Senka</au><au>Stojakovic, Tatjana</au><au>Scharnagl, Hubert</au><au>Kopecky, Chantal M</au><au>Rosenkranz, Alexander R</au><au>Heinemann, Akos</au><au>Marsche, Gunther</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dialysis Modalities and HDL Composition and Function</atitle><jtitle>Journal of the American Society of Nephrology</jtitle><addtitle>J Am Soc Nephrol</addtitle><date>2015-09-01</date><risdate>2015</risdate><volume>26</volume><issue>9</issue><spage>2267</spage><epage>2276</epage><pages>2267-2276</pages><issn>1046-6673</issn><eissn>1533-3450</eissn><abstract>Lipid abnormalities may have an effect on clinical outcomes of patients on dialysis. Recent studies have indicated that HDL dysfunction is a hallmark of ESRD. In this study, we compared HDL composition and metrics of HDL functionality in patients undergoing hemodialysis (HD) or peritoneal dialysis (PD) with those in healthy controls. We detected a marked suppression of several metrics of HDL functionality in patients on HD or PD. Compositional analysis revealed that HDL from both dialysis groups shifted toward a more proinflammatory phenotype with profound alterations in the lipid moiety and protein composition. With regard to function, cholesterol efflux and anti-inflammatory and antiapoptotic functions seemed to be more severely suppressed in patients on HD, whereas HDL-associated paraoxonase activity was lowest in patients on PD. Quantification of enzyme activities involved in HDL metabolism suggested that HDL particle maturation and remodeling are altered in patients on HD or PD. In summary, our study provides mechanistic insights into the formation of dysfunctional HDL in patients with ESRD who are on HD or PD.</abstract><cop>United States</cop><pub>American Society of Nephrology</pub><pmid>25745027</pmid><doi>10.1681/ASN.2014030309</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1046-6673
ispartof Journal of the American Society of Nephrology, 2015-09, Vol.26 (9), p.2267-2276
issn 1046-6673
1533-3450
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4552105
source PubMed Central Free; EZB-FREE-00999 freely available EZB journals
subjects 1-Alkyl-2-acetylglycerophosphocholine Esterase - metabolism
Aged
Aryldialkylphosphatase - metabolism
Case-Control Studies
Cells, Cultured
Cholesterol - metabolism
Cholesterol Ester Transfer Proteins - blood
Clinical Research
Female
Humans
Kidney Failure, Chronic - blood
Kidney Failure, Chronic - enzymology
Kidney Failure, Chronic - therapy
Lipopolysaccharides - pharmacology
Lipoprotein Lipase - blood
Lipoproteins, HDL - blood
Lipoproteins, HDL - chemistry
Lipoproteins, HDL - pharmacology
Macrophages - metabolism
Male
Middle Aged
Monocytes - drug effects
Monocytes - metabolism
NF-kappa B - metabolism
Peritoneal Dialysis
Phosphatidylcholine-Sterol O-Acyltransferase - blood
Phospholipid Transfer Proteins - blood
Renal Dialysis - methods
Triglycerides - blood
title Dialysis Modalities and HDL Composition and Function
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T09%3A32%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dialysis%20Modalities%20and%20HDL%20Composition%20and%20Function&rft.jtitle=Journal%20of%20the%20American%20Society%20of%20Nephrology&rft.au=Holzer,%20Michael&rft.date=2015-09-01&rft.volume=26&rft.issue=9&rft.spage=2267&rft.epage=2276&rft.pages=2267-2276&rft.issn=1046-6673&rft.eissn=1533-3450&rft_id=info:doi/10.1681/ASN.2014030309&rft_dat=%3Cproquest_pubme%3E1708903788%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c390t-553399dd4b46d015bc7632f5d19d9da2240731e77191094d26b58ef9b96408d33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1708903788&rft_id=info:pmid/25745027&rfr_iscdi=true